EE200100532A - 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat - Google Patents

5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat

Info

Publication number
EE200100532A
EE200100532A EEP200100532A EEP200100532A EE200100532A EE 200100532 A EE200100532 A EE 200100532A EE P200100532 A EEP200100532 A EE P200100532A EE P200100532 A EEP200100532 A EE P200100532A EE 200100532 A EE200100532 A EE 200100532A
Authority
EE
Estonia
Prior art keywords
methoxy
methylaminothiocarbonylaminosulfonylphenyl
benzamide
chloro
ethyl
Prior art date
Application number
EEP200100532A
Other languages
English (en)
Inventor
Christian Englert Heinrich
Gerlach Uwe
Metzenthin Tobias
Schneider Harald
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200100532A publication Critical patent/EE200100532A/et
Publication of EE04612B1 publication Critical patent/EE04612B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200100532A 1999-04-16 2000-04-04 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat EE04612B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (2)

Publication Number Publication Date
EE200100532A true EE200100532A (et) 2002-12-16
EE04612B1 EE04612B1 (et) 2006-04-17

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100532A EE04612B1 (et) 1999-04-16 2000-04-04 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat

Country Status (33)

Country Link
US (1) US6723751B1 (et)
EP (2) EP1637519B1 (et)
JP (1) JP4662640B2 (et)
KR (1) KR100700302B1 (et)
CN (1) CN1168712C (et)
AR (1) AR023479A1 (et)
AT (2) ATE414059T1 (et)
AU (1) AU773246B2 (et)
BR (1) BR0010658A (et)
CA (1) CA2370388C (et)
CZ (1) CZ302459B6 (et)
DE (3) DE19917233A1 (et)
DK (1) DK1173418T3 (et)
EE (1) EE04612B1 (et)
ES (1) ES2251996T3 (et)
HK (1) HK1046270B (et)
HR (1) HRP20010744B1 (et)
HU (1) HU229082B1 (et)
IL (2) IL145921A0 (et)
ME (1) MEP55708A (et)
MX (1) MXPA01010275A (et)
MY (1) MY122588A (et)
NO (1) NO327798B1 (et)
NZ (1) NZ514788A (et)
PL (1) PL203809B1 (et)
RS (1) RS50916B (et)
RU (1) RU2235089C2 (et)
SI (1) SI1173418T1 (et)
SK (1) SK287175B6 (et)
TR (2) TR200102993T2 (et)
TW (1) TWI276622B (et)
WO (1) WO2000063167A1 (et)
ZA (1) ZA200108400B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289507A1 (en) * 2003-03-17 2011-03-02 Japan Tobacco, Inc. Pharmaceutical compositions of CETP inhibitors
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2098069T3 (es) 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CZ301165B6 (cs) * 1998-09-10 2009-11-25 Sanofi - Aventis Deutschland GmbH Použití benzensulfonyl(thio)mocovin pro lécení a profylaxi dysfunkcí autonomní nervové soustavy a použití benzensulfonyl(thio)mocovin v kombinaci s beta-receptorovými blokátory

Also Published As

Publication number Publication date
DE60024431T2 (de) 2006-07-27
NZ514788A (en) 2003-03-28
ATE414059T1 (de) 2008-11-15
EE04612B1 (et) 2006-04-17
KR100700302B1 (ko) 2007-03-29
NO327798B1 (no) 2009-09-28
YU72001A (sh) 2004-07-15
DE60024431D1 (en) 2006-01-05
JP2002542230A (ja) 2002-12-10
HRP20010744B1 (en) 2010-08-31
SK287175B6 (sk) 2010-02-08
ATE311364T1 (de) 2005-12-15
DK1173418T3 (da) 2006-04-10
CN1354744A (zh) 2002-06-19
MXPA01010275A (es) 2003-07-21
AR023479A1 (es) 2002-09-04
MEP55708A (en) 2011-05-10
CA2370388A1 (en) 2000-10-26
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
CA2370388C (en) 2009-10-13
EP1637519A1 (en) 2006-03-22
HRP20010744A2 (en) 2003-04-30
HK1046270A1 (en) 2003-01-03
ES2251996T3 (es) 2006-05-16
CZ20013672A3 (cs) 2002-01-16
HK1046270B (zh) 2005-03-11
NO20015014D0 (no) 2001-10-15
PL351245A1 (en) 2003-04-07
US6723751B1 (en) 2004-04-20
EP1173418B1 (en) 2005-11-30
CN1168712C (zh) 2004-09-29
EP1637519B1 (en) 2008-11-12
IL145921A0 (en) 2002-07-25
EP1173418A1 (en) 2002-01-23
WO2000063167A1 (en) 2000-10-26
AU773246B2 (en) 2004-05-20
DE60040811D1 (de) 2008-12-24
BR0010658A (pt) 2002-02-19
TR200501142T2 (tr) 2005-08-22
RS50916B (sr) 2010-08-31
CZ302459B6 (cs) 2011-06-01
MY122588A (en) 2006-04-29
ZA200108400B (en) 2003-04-30
IL145921A (en) 2006-07-05
HUP0200791A2 (hu) 2002-07-29
TWI276622B (en) 2007-03-21
DE19917233A1 (de) 2000-10-19
HUP0200791A3 (en) 2005-04-28
JP4662640B2 (ja) 2011-03-30
AU4542800A (en) 2000-11-02
SI1173418T1 (sl) 2006-02-28
PL203809B1 (pl) 2009-11-30
NO20015014L (no) 2001-10-15
SK14582001A3 (sk) 2002-01-07
TR200102993T2 (tr) 2002-03-21
HU229082B1 (hu) 2013-07-29

Similar Documents

Publication Publication Date Title
EE200100529A (et) Diabeedivastase agensi uudsed polümorfsed vormid:nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
IT1289532B1 (it) Composti, di cloridrato di paroxetina e procedimenti per la loro preparazione
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
IS5989A (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
PL393385A1 (pl) Sposób modyfikacji i rekrystalizacji pokroju kryształów substancji leczniczej, kryształy mykofenolanu sodu i ich zastosowanie oraz kompozycja farmaceutyczna
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
EE04839B1 (et) Heterotsükliline benseensulfoonamiidühend, meetodühendi valmistamiseks, ühendi ja selle liitsoola kasutamine ning neid sisaldav terapeutiline kompositsioon
EE200100173A (et) 2-fenüülpüraan-4-ooni derivaadid, nende valmistamismeetod ja kasutamine, vaheühendite kasutamine jafarmatseutiline kompositsioon
EE200200331A (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0103712A3 (en) Salts of paroxetine, process for their preparation and their pharmaceutical use
EE04612B1 (et) 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat
EE200100417A (et) (1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE03873B1 (et) Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
NO20021527L (no) Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel
HUP9904011A3 (en) Novel salts of dipeptid derivatives and use of them for producing pharmaceutical compositions
FR2798930B1 (fr) Compose oxazoline-2 et procede de preparation de la trimebutine
EE200200053A (et) Isoretinoiini valmistamise protsess
HUP0100661A3 (en) Salts of paroxetine, process for their preparation and medicaments containing the compounds
ITMI992459A0 (it) Procedimento per la preparazione di marbofloxacina
FR2789990B1 (fr) Procede de preparation de derives d'aminobenzophenones

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150404